Brixadi (buprenorphine) Subcutaneous Injection, 96 mg Monthly Prefilled Syringe, 0.27 mL, Each
Brixadi is a brand-name prescription medication containing buprenorphine, used for the treatment of moderate to severe opioid use disorder. This product is a 96 mg monthly dose supplied as a prefilled syringe for subcutaneous injection, delivering 0.27 mL per syringe. It is intended for use in a healthcare setting or under medical supervision as part of a comprehensive treatment plan.
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Vendor Pricing Comparison
Sorted by lowest price · Add now, sign in at checkout
Brixadi is a brand-name prescription medication containing buprenorphine, used for the treatment of moderate to severe opioid use disorder. This product is a 96 mg monthly dose supplied as a prefilled syringe for subcutaneous injection, delivering 0.27 mL per syringe. It is intended for use in a healthcare setting or under medical supervision as part of a comprehensive treatment plan.
1 vendor
